June 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
August 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 950.00 million in 2025, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
August 2026
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
July 2026
The cell and gene therapy infrastructure market is expanding with scalable manufacturing, integrated delivery networks, and advanced clinical site readiness.
July 2026
Explore the cell and gene therapy patient access and reimbursement Market, driven by evolving payer policies, value-based care models, and rising adoption of high-cost cell and gene therapies.
July 2026
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
June 2026
The US cell and gene therapy market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 20.00 billion by 2035, growing at a CAGR of 17.21%.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global oncolytic virus therapy market size is evaluated at USD 3.71 billion in 2025 and is predicted to hit around USD 12.31 billion by 2035, growing at a CAGR of 12.74%.
June 2026
The global AAV gene therapy market size was evaluated at USD 2.85 billion in 2025 and is predicted to hit around USD 27.41 billion by 2035, with a CAGR of 25.39%.
May 2026
The global gene-replacement therapy market analysis covers market size, growth drivers, key players, pipeline advances, and regulatory trends shaping future demand.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
April 2026
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
January 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 6.31 billion in 2024, with a CAGR of 27.92%.
July 2025
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
July 2025
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 548.55 million in 2024, with a CAGR of 7.34%.
July 2025
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 11.60 billion in 2024, with a CAGR of 26.62%.
July 2025
The global nucleic acid therapeutics market size reached USD 5.77 billion in 2024 and is projected to surpass around USD 17.02 billion by 2034 with a solid CAGR of 11.42%.
September 2026
The cryotherapy market was valued at USD 11.18 billion in 2026, with leading companies including Brymill Cryogenic Systems, Metrum Cryoflex, Medtronic plc.
September 2026
The gene silencing market size stood at USD 4.98 billion in 2026, with major gene silencing companies including alnylam pharmaceuticals, arrowhead pharmaceuticals, dicerna pharmaceuticals, ionis pharmaceuticals.
September 2026
The nicotine replacement therapy market generated USD 108.61 billion in 2026, with prominent nicotine replacement therapy companies including Fertin Pharma, Philip Morris Products S.A., British American Tobacco plc, Glenmark Pharmaceuticals.
August 2026
The predictive genetic counselling market size stood at USD 3.54 billion in 2026, with major predictive genetic counselling market companies including Invitae Corporation, Myriad Genetics, Quest Diagnostics, Natera Inc. .
August 2026
The gene amplification technology market size reached USD 3.60 billion in 2025, with leading gene amplification technology market companies including Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Agilent Technologies, Inc.
August 2026
The direct-to-consumer genetic testing market reached USD 2.45 billion in 2026, featuring leading direct-to-consumer genetic testing companies such as Identigene, Karmagenes, Living DNA, Mapmygenome.
August 2026
The optogenetics market size reached USD 680.00 million in 2025, with leading optogenetics market companies including Thorlabs, Inc., Coherent Corp., Scientifica Ltd., Bruker Corporation, PerkinElmer, Inc.
August 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
August 2026
The generative AI in animation market reached USD 1.08 billion in 2025, with key generative AI in animation market companies including Adobe, Autodesk Inc., DreamWorks Animation, Google LLC, Kartoon Studios, Inc., NVIDIA Corporation.
August 2026
The synthetic data generation market reached USD 790.73 billion in 2026, with key synthetic data generation market companies including Mostly AI, Synthesis AI Statice, YData
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com